儿童手术患者输血与结局:北美11年回顾性队列研究
结果显示6.3%患儿接受输血,输血率从2016年4.7%升至2021年7%,输血与30天死亡率独立相关(调整OR 2.11,95%CI 1.95-2.27)。
要点
- 儿童非心脏手术围术期红细胞输血率为6.3%,11年间呈上升趋势。
- 输血患儿30天死亡率为2.4%,未输血患儿为0.2%(调整P<0.001)。
- 输血与30天死亡率独立相关(调整OR 2.11,95%CI 1.95-2.27)。
核心结论
- 儿童非心脏手术围术期红细胞输血率在11年间呈上升趋势,输血与30天死亡率及并发症独立相关。
主要发现
- 输血患儿30天死亡率为2.4%,未输血患儿为0.2%(调整P<0.001),输血组并发症更多(所有比较调整P<0.001)。
- 新生儿和≥12岁儿童输血暴露率较高,分别为13.3%和9.6%;新生儿30天死亡率14.9%,1-6岁儿童1.4%。
- 输血与30天死亡率独立相关(调整OR 2.11,95%CI 1.95-2.27)。
临床怎么用
- 围术期应持续警惕儿童输血管理,对出血和贫血患儿采取针对性干预以降低相关风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paediatric perioperative blood transfusion trends remain poorly described. The purpose of this study was to determine the incidence and associated outcomes of red blood cell (RBC) transfusion in paediatric surgical patients over a recent decade in North America. METHODS: This retrospective cohort study utilised data from the American College of Surgeons National Surgical Quality Improvement Program paediatric databases spanning a decade. Patients aged 0-18 yr who underwent noncardiac surgery were included. Patient characteristics and outcome variables were compared between patients exposed to a transfusion and those who were not using the Wilcoxon rank sum test for continuous variables and χ2 test for categorical variables. The association between RBC transfusion and outcomes was analysed by multivariable logistic regression models. The primary aim was to describe the incidence of RBC transfusion for paediatric surgery over an 11-yr period. The secondary aim was to assess the relationship between RBC transfusion and adverse outcomes according to age groups and volumes transfused. RESULTS: Among the 1 303 500 paediatric patients included during 2012-23, 82 742 (6.3%) received RBC transfusion in the perioperative period (defined as intraoperatively up to 72 h after surgery). There was an upward trajectory in paediatric transfusions over the 11-yr period, ranging from 4.7% (2016) to 7% (2021). The 30-day mortality rate in those transfused was 2.4% compared with 0.2% in those not transfused (adjusted P-value <0.001). Those transfused experienced more complications (adjusted P-value <0.001 for all comparisons) which was distinct for higher volumes given. Neonates and older children (≥12 yr old) had higher transfusion exposure at 13.3% and 9.6%, respectively. Neonates and children had higher associated rates of 30-day mortality (14.9% for neonates, 1.4% for children aged 1-6 yr) and adverse outcomes. Comparing death at 30 days with and without blood transfusion, there was an independent association between transfusion and 30-day mortality (adjusted odds ratio 2.11, 95% confidence interval 1.95-2.27). CONCLUSIONS: We describe the incidence of RBC transfusion and associated mortality over a decade for paediatric patients undergoing noncardiac surgery. Ongoing vigilance in perioperative transfusion management and tailored interventions to mitigate associated risks and optimise perioperative outcomes are needed in bleeding and anaemic paediatric surgical patients.
引用
- Goobie SM, Faraoni D. Transfusion and outcomes in paediatric surgical patients: an 11-year retrospective North American cohort study. Br J Anaesth. 2025. PMID: 41274808. doi:10.1016/j.bja.2025.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。